U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Sodium Bicarbonate Injection
Status: Currently in Shortage
»Date first posted: 03/01/2017
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric

Expand all

Amphastar Pharmaceuticals, Inc. (Reverified 02/08/2024)

Company Contact Information:
800-423-4136

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 84 mg/1 mL (NDC 76329-3352-1) Backorder due to the increase in demands, On allocation Demand increase for the drug

Exela Pharma Sciences, LLC (Reverified 02/01/2024)

Company Contact Information:
828-758-5474 ext. 154

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 84 mg/1 mL (NDC 51754-5001-5) Available Available in NDC 51754-5001-4 which is carton of 25 vials. The 521754-5001-05 was discontinued over a year ago.
Injection, 84 mg/1 mL (NDC 51754-5011-4) All Backorders shipped, limited stock on hand for allocations. Demand increase for the drug
Injection, 42 mg/1 mL (NDC 51754-5012-4) Batch pending release will be allocated to fill backlog, 10 days Demand increase for the drug

Fresenius Kabi USA, LLC (Reverified 02/01/2024)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 42 mg/1 mL (NDC 63323-083-05) Available Check wholesalers for inventory
Injection, 84 mg/1 mL (NDC 63323-089-50) Available Check wholesalers for inventory

Hospira, Inc., a Pfizer Company (Revised 02/27/2024)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 0409-5534-14) Limited Availability, 3Q 2024 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay

Dear Customer Letter: Emergency Syringe Availability Update

Delay in shipping of the drug
Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 0409-6637-14) Unavailable, 1Q 2025 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay

Dear Customer Letter: Emergency Syringe Availability Update

Delay in shipping of the drug
Injection, 42 mg/1 mL (NDC 0409-5555-02) Limited Availability, 2Q 2024 Demand increase for the drug
Injection, 42 mg/1 mL (NDC 0409-5555-01) Unavailable, 2Q 2024 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Delay in shipping of the drug
Injection, 75 mg/1 mL (NDC 0409-4916-14) Unavailable, 4Q 2024 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay

Dear Customer Letter: Emergency Syringe Availability Update

Delay in shipping of the drug
Injection, 84 mg/1 mL (NDC 0409-6625-14) Limited Availability, 2Q 2024 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay

Dear Customer Letter: Availability Update for Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL)

Delay in shipping of the drug
Injection, 84 mg/1 mL (NDC 0409-6625-35) Unavailable, 2Q 2025 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Delay in shipping of the drug
Injection, 84 mg/1 mL (NDC 0409-4900-14) Unavailable, 3Q 2024 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay

Dear Customer Letter: Emergency Syringe Availability Update

Delay in shipping of the drug
Back to Top